These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29422652)

  • 21. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.
    Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR
    Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineralocorticoid receptor activation: a major contributor to salt-induced renal injury and hypertension in young rats.
    Kawarazaki H; Ando K; Fujita M; Matsui H; Nagae A; Muraoka K; Kawarasaki C; Fujita T
    Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1402-9. PubMed ID: 21478481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mineralocorticoid receptor--Rac1 activation and oxidative stress play major roles in salt-induced hypertension and kidney injury in prepubertal rats.
    Kawarazaki H; Ando K; Shibata S; Muraoka K; Fujita M; Kawarasaki C; Fujita T
    J Hypertens; 2012 Oct; 30(10):1977-85. PubMed ID: 22914542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.
    Manhiani M; Quigley JE; Knight SF; Tasoobshirazi S; Moore T; Brands MW; Hammock BD; Imig JD
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F740-8. PubMed ID: 19553349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM; Chung TH; Lin SZ; Chang NC
    J Hypertens; 2014 Apr; 32(4):795-805. PubMed ID: 24463935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms.
    Iacobini C; Menini S; Ricci C; Scipioni A; Sansoni V; Mazzitelli G; Cordone S; Pesce C; Pugliese F; Pricci F; Pugliese G
    J Pathol; 2009 Jul; 218(3):360-9. PubMed ID: 19334049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension.
    Hisamichi M; Kamijo-Ikemori A; Sugaya T; Ichikawa D; Natsuki T; Hoshino S; Kimura K; Shibagaki Y
    FASEB J; 2017 Jan; 31(1):72-84. PubMed ID: 27663860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary Potassium Supplementation Reduces Chronic Kidney Lesions Independent of Blood Pressure in Deoxycorticosterone-Acetate and High Sodium Chloride-Treated Mice.
    Wang Q; Schäfer SC; Haefliger JA; Maillard MP; Alonso F
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension.
    Quigley JE; Elmarakby AA; Knight SF; Manhiani MM; Stepp DW; Olearzcyk JJ; Imig JD
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):724-8. PubMed ID: 19207724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway.
    Shibata S; Mu S; Kawarazaki H; Muraoka K; Ishizawa K; Yoshida S; Kawarazaki W; Takeuchi M; Ayuzawa N; Miyoshi J; Takai Y; Ishikawa A; Shimosawa T; Ando K; Nagase M; Fujita T
    J Clin Invest; 2011 Aug; 121(8):3233-43. PubMed ID: 21765214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress.
    Nagase M; Matsui H; Shibata S; Gotoda T; Fujita T
    Hypertension; 2007 Nov; 50(5):877-83. PubMed ID: 17875821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term administration of advanced glycation end-product stimulates the activation of NLRP3 inflammasome and sparking the development of renal injury.
    Yeh WJ; Yang HY; Pai MH; Wu CH; Chen JR
    J Nutr Biochem; 2017 Jan; 39():68-76. PubMed ID: 27816762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
    Ndisang JF; Jadhav A
    J Pharmacol Exp Ther; 2010 Jul; 334(1):87-98. PubMed ID: 20392817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integral role of receptor for advanced glycation end products (RAGE) in nondiabetic atherosclerosis.
    Uekita H; Ishibashi T; Shiomi M; Koyama H; Ohtsuka S; Yamamoto H; Yamagishi S; Inoue H; Itabe H; Sugimoto K; Kamioka M; Ohkawara H; Wada I; Yasuchika T
    Fukushima J Med Sci; 2019; 65(3):109-121. PubMed ID: 31915324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome.
    Fujita T
    Hypertension; 2010 Apr; 55(4):813-8. PubMed ID: 20176994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decoding the role of aldosterone in glycation-induced diabetic complications.
    Apte M; Zambre S; Pisar P; Roy B; Tupe R
    Biochem Biophys Res Commun; 2024 Aug; 721():150107. PubMed ID: 38781658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced expression of bone morphogenetic protein system in aldosterone-treated mouse kidneys.
    Suzuki J; Otsuka F; Matsumoto Y; Inagaki K; Miyoshi T; Takeda M; Tsukamoto N; Nakamura E; Ogura K; Makino H
    Hypertens Res; 2012 Mar; 35(3):312-7. PubMed ID: 22072104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension.
    Ji X; Naito Y; Weng H; Endo K; Ma X; Iwai N
    Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1207-15. PubMed ID: 22859404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JMJD3 ablation in myeloid cells confers renoprotection in mice with DOCA/salt-induced hypertension.
    Gao Y; Yu W; Song J; Nie J; Cui Z; Wen S; Liu B; Liang H
    Hypertens Res; 2023 Aug; 46(8):1934-1948. PubMed ID: 37248323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA-Aptamer Raised against Receptor for Advanced Glycation End Products Improves Survival Rate in Septic Mice.
    Koga Y; Sotokawauchi A; Higashimoto Y; Nishino Y; Hashizume N; Kakuma T; Akiba J; Tanaka Y; Matsui T; Yagi M; Yamagishi SI
    Oxid Med Cell Longev; 2021; 2021():9932311. PubMed ID: 34413930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.